Advances in Omics Technologies (Technical Insights)


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service provides an assessment of key component technology areas within the omics space, and offers insights and recommendations for managing the R&D portfolio effectively. Incorporated analysis includes a strategic evaluation of R&D portfolio within this space using a multicriteria decision making tool, an assessment of research orientation among key focus areas in the industry, analysis of the challenging environment for R&D, and an overview of emerging market needs. Finally, a discussion of future R&D trends and insights on strategically managing the R&D pipeline is also included.

Table of Contents

Advances in Omics Technologies (Technical Insights), Executive SummaryResearch Scope and MethodologyScope of the Research ServiceMethodologyResearch OverviewAn Introduction to OmicsClassification of Omics-based TechnologyApplication of Omics Across Industries and AcademiaAdvances in Omics Technologies (Technical Insights), Strategic Assessment of the Industry EnvironmentR&D Portfolio Analysis Research PortfolioR&D Budgetary AnalysisOmics Technology Platforms--Diagnostics and TherapeuticsResearch OrientationFocus of Omics PlatformsOmics-based Diagnostics for CancerOmics-based Diagnostics for Neurological DisordersOmics-based Diagnostics for Cardiovascular DiseasesOmics-based Diagnostics for Renal and Hepatic DiseasesOmics-based Diagnostics for Infectious DiseasesEnvironmental AnalysisFactors Accelerating Technology DevelopmentEmerging Market NeedsKey Technical ChallengesKey Business ChallengesRestraints for Technology DevelopmentAdvances in Omics Technologies (Technical Insights), Strategic Evaluation of R&D PortfolioTechnology Development Market LandscapeIndustry Best Practices and Strategic Insights Assessment of Partnerships/AlliancesStrategic Recommendations (AHP Analysis)Advances in Omics Technologies (Technical Insights), Patents; Contacts; and AppendixKey Patents and AppendixKey PatentsContactsContacts--Part 1Appendix A1: Analytical Hierarchy ProcessContacts--Part 2Advances in Omics Technologies (Technical Insights), Decision Support TablesCritical Reference TablesPharma Research and Development Expenditure (2006 To 2016)Percentage Pharma Research and Development Expenditure (2006 To 2016)Number of Biotech Companies (2006 To 2016)

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.